RBC Capital raised the firm’s price target on UiPath (PATH) to $14 from $12 and keeps a Sector Perform rating on the shares as part of a broader ...

UiPath is entering a new market for AI solutions through strategic partnerships that will take it to the next level of ...

UiPath's strategy reflects a company that's no longer chasing automation hype -- it's laying the groundwork for durable, ...

UiPath CEO Daniel Dines advocates for agentic AI as the next frontier in enterprise automation, complementing RPA by ...

Palantir ( PLTR +1.65%) and UiPath ( PATH +1.20%) are both well poised to profit from the secular expansion of the artificial ...

The stock jumped 13% on that day, and continued to gained from there, peaking on Oct. 9, up 18.8% as Time magazine called UiPath Agentic Automation one of the best inventions of 2025, noting that ...

Journal Editorial Report: The candidates square off over Trump and taxes as the polls tighten. When ballots are counted across America in less than two weeks, the punditry will focus on the New York ...

6 analysts have expressed a variety of opinions on UiPath (NYSE:PATH) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview ...

Broadcom and UiPath have big growth potential. If you're looking to put money to work in the market -- say $1,000 -- investing in some up-and-coming growth stocks could be a good route to take. Let's ...

Sign up now: Get ST's newsletters delivered to your inbox A review panel found failures in the system regarding Megan Khung's death, including missed chances to save ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Scientists have used an eye implant to improve the vision of dozens of people left functionally blind by age-related macular degeneration (AMD). The implant, which measures 2 millimetres by 2 ...